A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

We explored the role of hypocretins in human narcolepsy through histopathology of six narcolepsy brains and mutation screening of Hcrt, Hcrtr1 and Hcrtr2 in 74 patients of various human leukocyte antigen and family history status. One Hcrt mutation, impairing peptide trafficking and processing, was found in a single case with early onset narcolepsy. In situ hybridization of the perifornical area and peptide radioimmunoassays indicated global loss of hypocretins, without gliosis or signs of inflammation in all human cases examined. Although hypocretin loci do not contribute significantly to genetic predisposition, most cases of human narcolepsy are associated with a deficient hypocretin system.

[1]  T. Sakurai,et al.  Structure and Function of Human Prepro-orexin Gene* , 1999, The Journal of Biological Chemistry.

[2]  M. Ghatei,et al.  Distribution and quantification of immunoreactive orexin A in rat tissues , 1999, FEBS letters.

[3]  J. Battey,et al.  Molecular analysis of autosomal dominant neurohypophyseal diabetes insipidus. , 1990, The Journal of clinical endocrinology and metabolism.

[4]  Henry M. Kronenberg,et al.  Inefficient Membrane Targeting, Translocation, and Proteolytic Processing by Signal Peptidase of a Mutant Preproparathyroid Hormone Protein (*) , 1995, The Journal of Biological Chemistry.

[5]  E. Mignot,et al.  Narcolepsy and immunity. , 1995, Advances in neuroimmunology.

[6]  M. Billiard,et al.  Autoimmune hypothesis in narcolepsy , 1993, Neurophysiologie Clinique/Clinical Neurophysiology.

[7]  M. Nakazato,et al.  Characterization of orexin-A and orexin-B in the microdissected rat brain nuclei and their contents in two obese rat models , 1999, Neuroscience Letters.

[8]  D. Daly,et al.  Narcolepsy in children. , 1960, Pediatrics.

[9]  J. Montplaisir,et al.  The effects of L-dopa on periodic leg movements and sleep organization in narcolepsy. , 1989, Clinical neuropharmacology.

[10]  C. Bouras,et al.  Mapping of cocaine and amphetamine regulated transcript (CART) mRNA expression in the hypothalamus of elderly human , 1999, Journal of Chemical Neuroanatomy.

[11]  T. Hökfelt,et al.  Hypocretin/Orexin‐ and melanin‐concentrating hormone‐expressing cells form distinct populations in the rodent lateral hypothalamus: Relationship to the neuropeptide Y and agouti gene‐related protein systems , 1998, The Journal of comparative neurology.

[12]  S. Carr,et al.  Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding Behavior , 1998, Cell.

[13]  D. Repaske,et al.  Autosomal dominant neurohypophyseal diabetes insipidus associated with a missense mutation encoding Gly23-->Val in neurophysin II. , 1997, The Journal of clinical endocrinology and metabolism.

[14]  Sebastiaan Overeem,et al.  Hypocretin (orexin) deficiency in human narcolepsy , 2000, The Lancet.

[15]  Jon T. Willie,et al.  Narcolepsy in orexin Knockout Mice Molecular Genetics of Sleep Regulation , 1999, Cell.

[16]  E. Mignot,et al.  PHARMACOLOGICAL ASPECTS OF HUMAN AND CANINE NARCOLEPSY , 1997, Progress in Neurobiology.

[17]  M. I. Smith,et al.  Orexin A activates locus coeruleus cell firing and increases arousal in the rat. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Guilleminault,et al.  Sleep/Wake Disorders: Natural History, Epidemiology, and Long-Term Evolution. , 1984 .

[19]  C. Peyron,et al.  The hypocretin/orexin ligand–receptor system: implications for sleep and sleep disorders , 2000, Trends in Neurosciences.

[20]  Noth,et al.  Dynamics of microglial activation in the spinal cord after cerebral infarction are revealed by expression of MHC class II antigen , 1998, Neuropathology and applied neurobiology.

[21]  R. Scheller,et al.  Three Novel Proteins of the Syntaxin/SNAP-25 Family* , 1998, The Journal of Biological Chemistry.

[22]  M. Satake,et al.  HLA antigens in Japanese patients with narcolepsy , 1984 .

[23]  M. Satake,et al.  HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. , 1984, Tissue antigens.

[24]  M. Aldrich,et al.  Major Histocompatibility Class II Molecules in the CNS: Increased Microglial Expression at the Onset of Narcolepsy in a Canine Model , 1996, The Journal of Neuroscience.

[25]  F E Bloom,et al.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Burbach,et al.  Mutations in the Vasopressin Prohormone Involved in Diabetes Insipidus Impair Endoplasmic Reticulum Export but Not Sorting* , 1999, The Journal of Biological Chemistry.

[27]  S. Carr,et al.  Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. , 1998, Cell.

[28]  G. Paxinos,et al.  Atlas of the Human Brain , 2000 .

[29]  P. Underhill,et al.  DQB1*0602 and DQA1*0102 (DQ1) are better markers than DR2 for narcolepsy in Caucasian and black Americans. , 1994, Sleep.

[30]  C. Guilleminault,et al.  Narcolepsy in prepubertal children , 1998, Annals of neurology.

[31]  Mignot,et al.  Perspectives in narcolepsy and hypocretin (orexin) research. , 2000, Sleep medicine.

[32]  A. N. van den Pol,et al.  Neurons Containing Hypocretin (Orexin) Project to Multiple Neuronal Systems , 1998, The Journal of Neuroscience.

[33]  G. Barsh,et al.  Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area , 1998, The Journal of comparative neurology.

[34]  Emmanuel Mignot,et al.  The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene , 1999, Cell.

[35]  C. Guilleminault,et al.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. , 1997, Sleep.

[36]  E. Mignot,et al.  Heterozygosity at the canarc-1 locus can confer susceptibility for narcolepsy: induction of cataplexy in heterozygous asymptomatic dogs after administration of a combination of drugs acting on monoaminergic and cholinergic systems , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  E. Mignot,et al.  Genetic and familial aspects of narcolepsy , 1998, Neurology.

[38]  George Kollias,et al.  The function of tumour necrosis factor and receptors in models of multi-organ inflammation, rheumatoid arthritis, multiple sclerosis and inflammatory bowel disease , 1999, Annals of the rheumatic diseases.

[39]  M. Ito,et al.  Molecular basis of autosomal dominant neurohypophyseal diabetes insipidus. Cellular toxicity caused by the accumulation of mutant vasopressin precursors within the endoplasmic reticulum. , 1997, The Journal of clinical investigation.

[40]  R. Hayduk,et al.  Clinical and polysomnographic features in DQB1*0602 positive and negative narcolepsy patients: results from the modafinil clinical trial. , 2000, Sleep medicine.